Combretum sericeum
Combretum sericeum · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Combretum sericeum is a remarkable botanical species recognized for its diverse pharmacological potential. Scientific investigations have highlighted its significant antibacterial, anticancer, and antifungal activities. These therapeutic properties make it a valuable resource for managing physical ailments such as bone fractures, sprains, and wounds. Researchers are actively studying the specific compounds isolated from the plant to better understand its medicinal mechanisms. Consequently, this plant represents a promising subject for future drug development and traditional healing practices.
- Synonyms
- Combretum Herbaceum · Combretum Zastrowii · 8 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Combretum sericeum is a complex species characterized by several taxonomic synonyms within botanical literature. Researchers have historically identified this plant under various names, including Combretum argyrochryseum and Combretum herbaceum. It has also been documented in scientific records as Combretum katangense and Combretum lineare. Furthermore, the name Combretum parvulum has been applied to specimens previously categorized under this lineage. Navigating these overlapping designations is essential for maintaining accurate botanical classifications.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Combretum sericeum is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species is categorized under the class Equisetopsida. It further belongs to the specific order Myrtales, which helps define its evolutionary lineage. This plant is a representative of the genus Combretum, showcasing unique morphological traits. Finally, it is classified within the Combretaceae family, situating it among its closest botanical relatives.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Combretum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Combretum sericeum exhibits a broad geographic presence across the African continent, spanning diverse ecological zones. Its range extends through East Tropical Africa, with notable populations found in Tanzania. The species is also well-established in Northeast Tropical Africa, appearing in regions such as Chad and the territories of Sudan and South Sudan. Moving toward the southern reaches of the continent, it maintains a presence in South Tropical Africa. This widespread distribution is further evidenced by its occurrence in both Angola and Malawi.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Combretum sericeum is a versatile shrub that maintains a self-supporting growth habit. This plant typically reaches a maximum height of 2 meters, though it can remain quite small. Depending on its environment, individual specimens may grow as little as 0.15 meters tall. Such a flexible stature allows this species to adapt effectively to various landscape settings.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Combretum sericeum possesses a diverse range of biological properties that make it a subject of significant pharmacological interest. Research indicates that this plant exhibits notable antibacterial activity, which is essential for combating various bacterial infections. Furthermore, it demonstrates potent antifungal capabilities, offering a natural defense against fungal pathogens. The plant is also recognized for its anticancer activity, showing promise in the inhibition of harmful cell growth. These combined therapeutic effects highlight the significant medicinal potential of the species in modern drug development.
Compounds
Conditions
Combretum sericeum is utilized in traditional medicine to treat bone fractures, wounds, and sprains. In the northern region of the Republic of Benin, this plant is specifically reported to strengthen bones and promote healing. Beyond its musculoskeletal applications, research indicates that the plant can also be used to treat HL-60 cancer cell lines. Furthermore, it has demonstrated the ability to treat Jurkat T cells in laboratory settings. These diverse medicinal properties highlight the plant's significant potential for treating both physical injuries and specific cancerous cell lines.
Preparations
Combretum sericeum is not mentioned in the provided abstract as a source for any isolated chemical components. The research specifically focuses on the medicinal properties of compounds derived from Combretum zeyheri and Combretum platypetalum. While the text details how various isolated compounds from these two species are prepared for testing, it does not provide data regarding Combretum sericeum. Consequently, no relationship can be established between Combretum sericeum and the prepared compounds discussed in the study. The study's findings remain limited to the efficacy of extracts from the other two identified species.